A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523355-59-00

Acronym

QL0911-102

Enrollment

Registered

2026-01-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic Syndrome of Acute Radiation Syndrome, Immune Thrombocytopenia

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026